Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis
article
OA: closed
CC0
⤵ 117 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study compared depot medroxyprogesterone acetate to an oral contraceptive plus low-dose danazol for long-term treatment of endometriosis-related pelvic pain.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (29)
- A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex
- Buserelin versus danazol in the treatment of endometriosis-associated infertility via openalex
- Comparison of Cyproterone Acetate and Danazol in the Treatment of Pelvic Pain Associated With Endometriosis via openalex
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness via openalex
- Endometriosis and pelvic pain via openalex
- Endometriosis therapy with medroxyprogesterone acetate. via openalex
- Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. via openalex
- Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
- Improving the classification of endometriosis* via openalex
- Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex
- MANAGEMENT OF ENDOMETRIOSIS WITH ORAL MEDROXYPROGESTERONE ACETATE via openalex
- Medical treatment of mild endometriosis in infertile women: analysis of a failure via openalex
- Reduction of the intraperitoneal inflammation associated with endometriosis by treatment with medroxyprogesterone acetate via openalex
- Treatment of endometriosis associated with pain via openalex
- Treatment of Endometriosis with Estrogen-Progestin Combination and Progestogens Alone via openalex
- W6714620062 via openalex
- W2041529679 via openalex
- W2057341201 via openalex
- W2072195133 via openalex
- W2082970080 via openalex
- W2089014743 via openalex
- W2089311861 via openalex
- W2114111686 via openalex
- W2155119058 via openalex
- W2412063026 via openalex
- W2477008945 via openalex
- W4246620093 via openalex
- W6600720097 via openalex
- W6633460794 via openalex
Cited by (50)
- Safety of current strategies to manage moderate to severe pain in patients with endometriosis 2025
- Progestagens for pain symptoms associated with endometriosis 2025
- Hormonal Treatment of Endometriosis: A Narrative Review 2025
- Safety and efficacy of pharmacotherapies for pelvic inflammatory disease and endometriosis 2024
- Comparison of dienogest or combinations with ethinylestradiol/estradiol valerate on the pain score of women with endometriosis: A prospective cohort study 2024
- A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action 2024
- Neuroimmunology of Endometriosis-Associated Pain and Its Psychological Aspects 2024
- Management of endometriosis: a call to multidisciplinary approach 2024
- Hormonal Therapy in Endometriosis and Adenomyosis: Danazol, Aromatase Inhibitors 2022
- Hormonal Therapy in Endometriosis and Adenomyosis: Progestins 2022
- The use of progestin subdermal implants in the management of endometriosis-related pain symptoms and quality of life: a systematic review 2022
- Progestogens and Endometriosis 2021
- Endometriose Aspectos clínicos do diagnóstico ao tratamento 2021
- Endometriosis Treatment 2020
- Do high‐dose progestins impair sexual function in women treated for endometriosis? A prospective observational longitudinal study 2020
- Endometriosis in Adolescent Girls 2020
- Tratamientos farmacológicos de la endometriosis (a excepción de la adenomiosis) 2018
- Medical treatment of endometriosis-related pain 2018
- Current and emerging treatment options for endometriosis 2018
- Current and Emerging Therapeutics for the Management of Endometriosis 2018
- Reviewing the role of progesterone therapy in endometriosis 2018
- Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis 2018
- Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal. RPC Endométriose CNGOF-HAS 2018
- Drug delivery for the treatment of endometriosis and uterine fibroids 2017
- Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal et perspectives thérapeutiques 2017
- Postoperative desogestrel for pelvic endometriosis-related pain: a randomized controlled trial 2017
- Oral and depot progestin therapy for endometriosis: towards a personalized medicine 2017
- Adolescent endometriosis 2017
- Development of <i>N</i>-(4-Phenoxyphenyl)benzenesulfonamide Derivatives as Novel Nonsteroidal Progesterone Receptor Antagonists 2016
- Overview of elagolix for the treatment of endometriosis 2016
- Hormonal therapy for endometriosis: from molecular research to bedside 2016
- ENDOMETRİOZİSE BAĞLI AĞRI TEDAVİSİNDE LEVONORGESTREL SALGILAYAN RAHİM İÇİ ARAÇ SİSTEMİ (LNG-RİA) VE NAPROKSEN SODYUM ETKİNLİĞİ KARŞILAŞTIRILMASI 2016
- Is Idiopathic Chronic Pelvic Pain a Treatable Entity: A Comment 2016
- Progestin suppressed inflammation and cell viability of tumor necrosis factor‐α‐stimulated endometriotic stromal cells 2016
- Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial 2016
- Treatment of pain associated with deep endometriosis: alternatives and evidence 2015
- Measures Used to Assess Chronic Pelvic Pain in Randomized Controlled Clinical Trials: A Systematic Review 2015
- Progestin Therapy in Endometriosis 2015
- Progestogens and Endometriosis 2015
- Triptorelin for the treatment of endometriosis 2014
- Ovarian hormones and chronic pain: A comprehensive review 2014
- Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function 2014
- Systematic review of endometriosis pain assessment: how to choose a scale? 2014
- Endometriosis: An Update on Management 2013
- Traitements médicaux des tumeurs ovariennes présumées bénignes 2013
- Systematic Review of Therapies for Noncyclic Chronic Pelvic Pain in Women 2012
- Noncyclic Chronic Pelvic Pain Therapies for Women: Comparative Effectiveness 2012
- The current place of progestins in the treatment of endometriosis 2012
- Progestagens and anti-progestagens for pain associated with endometriosis 2012
- Ovulation‐Inhibiting Effects of Dienogest in a Randomized, Dose‐Controlled Pharmacodynamic Trial of Healthy Women 2011
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:11:02.671803+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK